Gastric cancer (GC) with peritoneal metastases and malignant ascites continues to have
poor prognosis. Exosomes mediate intercellular communication during cancer progression …

Peritoneal dissemination (PD) is the most frequent metastasis with poor prognosis in
patients with advanced gastric cancer (GC). However, the molecular mechanisms of PD …

Gastric cancer (GC) development is a complex process displaying polytropic cell and
molecular landscape within gastric tumor microenvironment (TME). Stromal cells in TME …

Gastrointestinal tumours are the most common solid tumours, with a poor prognosis and
remain a major challenge in cancer treatment. Mesenchymal stem cells (MSC) are …

Cancer is one of the most important health problems and the second leading cause of death
worldwide. Despite the advances in oncology, cancer heterogeneity remains challenging to …

Gastric cancer has a high rate of metastasis, during which pre-metastatic niches (PMN)
provide a supportive environment for the upcoming tumor cells. Exosomes are bilayer …

An intact mesothelium serves as a protective barrier to inhibit peritoneal carcinomatosis.
Cancer‐derived exosomes can mediate directional tumor metastasis; however, little is …

Exosomes participate in cancer progression and metastasis by transferring bioactive
molecules between cancer and various cells in the local and distant microenvironments …

Exosomes have emerged as a new drug delivery system. In particular, exosomes derived
from mesenchymal stem cells (MSCs) have been extensively studied because of their tumor …

Liver metastasis is one of the major causes of colorectal cancer (CRC)-related morbidity and
mortality. Delivering small interfering RNAs (siRNAs) or noncoding RNAs has been reported …